---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-25-000077"
form_type: "8-K"
ticker: "CNSP"
cik: "0001729427"
company_name: "CNS Pharmaceuticals, Inc."
filed_at: "2025-01-03T23:59:59+00:00"
generated_at: "2026-05-28T14:40:24.225994+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# CNS Pharmaceuticals sold 17.5M shares via ATM; shares outstanding now 74.96M

## Summary
- Sold 17,475,827 shares under at-the-market agreement since last 10-Q (Sept 30, 2024).
- As of Jan 3, 2025, common shares outstanding increased to 74,962,533 from ~57.5M.
- No disclosure of pricing or use of proceeds; significant dilution (~30%) for existing holders.

## SEC filing metadata
- accession: 0001683168-25-000077
- form_type: 8-K
- ticker: CNSP
- cik: 0001729427
- company_name: CNS Pharmaceuticals, Inc.
- filed_at: 2025-01-03T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1729427/000168316825000077/0001683168-25-000077-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1729427/000168316825000077/cns_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-25-000077
- JSON: https://secwatch.observer/filing/0001683168-25-000077.json
- Plain text: https://secwatch.observer/filing/0001683168-25-000077.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.